Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol
May 04, 2021 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...
Optimi Health Receives Health Canada NPN Product Licenses in Preparation for Q2 Sales Launch
March 16, 2021 09:00 ET
|
Optimi Health Corp.
--Company Introduces Celebrity Wellness Expert Harley Pasternak as Advisor VANCOUVER, British Columbia, March 16, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (“Optimi” or the...
Optimi Health Accelerates Psilocybin Clinical Trial Program with IMPACT
March 09, 2021 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, March 09, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused...
OPTIMI HEALTH and NUMINUS WELLNESS to Conduct Psychedelic Lab Research and Development
March 02, 2021 09:00 ET
|
Optimi Health Corp.
Agreement propels development of safe and effective proprietary products and formulations for the emerging psychedelic industry VANCOUVER, British Columbia, March 02, 2021 (GLOBE NEWSWIRE) --...